Companies much like the FDA and DEA strongly caution against using artificial cannabinoids because of their association with major clinical incidents.Chemical components of each and every packet of synthetic cannabinoids are extremely variable, that makes them quite challenging to track, watch, and continue to render unlawful. Because 2010 syntheti